|
Volumn 23, Issue 2, 2008, Pages 298-305
|
Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina
|
Author keywords
Endometrium; Estradiol tibolone; Gene expression; Myometrium; Vagina
|
Indexed keywords
ESTRADIOL;
HORMONE RECEPTOR;
MEDROXYPROGESTERONE ACETATE;
RNA;
TIBOLONE;
PREGNANE DERIVATIVE;
APOPTOSIS;
ARTICLE;
CELL ASSAY;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CLUSTER ANALYSIS;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ENDOMETRIUM;
ESTROGEN ACTIVITY;
ESTROGEN THERAPY;
FEMALE;
GENE CONTROL;
GENE EXPRESSION PROFILING;
HORMONAL REGULATION;
HORMONAL THERAPY;
HORMONE ACTION;
HORMONE RESPONSE;
HUMAN;
HUMAN TISSUE;
HYSTERECTOMY;
IMMUNOHISTOCHEMISTRY;
MICROARRAY ANALYSIS;
MONOTHERAPY;
MYOMETRIUM;
POSTMENOPAUSE;
RNA ANALYSIS;
RNA ISOLATION;
SIGNAL TRANSDUCTION;
STEROID METABOLISM;
UTERUS;
VAGINA;
COMPARATIVE STUDY;
DRUG COMBINATION;
DRUG EFFECT;
GENE EXPRESSION;
METABOLISM;
CLUSTER ANALYSIS;
DRUG THERAPY, COMBINATION;
ENDOMETRIUM;
ESTRADIOL;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
GENE EXPRESSION;
GENE EXPRESSION PROFILING;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MYOMETRIUM;
NORPREGNENES;
SIGNAL TRANSDUCTION;
VAGINA;
|
EID: 40349085645
PISSN: 02681161
EISSN: 14602350
Source Type: Journal
DOI: 10.1093/humrep/dem366 Document Type: Article |
Times cited : (8)
|
References (43)
|